Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. M. Adcock (London, United Kingdom). Potential drugs to treat smokers with asthma. Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients

Member's Comments

No comment yet.

Related content which might interest you: Can smoking asthmatic subjects benefit from anti-asthmatic treatment? Source: Eur Respir J 2007; 30: Suppl. 51, 15s Year: 2007 Comorbidities – should we and how should we treat them in asthma and COPD? Source: International Congress 2014 – PG02 Current clinical problems in pulmonology Year: 2014 Combination asthma medication and healthcare use in severe or difficult-to-treat asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004 Features of anti-inflammatory therapy of bronchial asthma in children with overweight andobesity Source: Virtual Congress 2020 – Paediatric asthma Year: 2020 Restoring corticosteroid sensitivity in COPD and smokers with asthma Source: Annual Congress 2008 - Smokers with asthma versus COPD: differences and similarities Year: 2008 Comparative effectiveness of add-on omalizumab for the treatment of severe persistent asthma between current and former smokers vs. non-smokers Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Cost of asthma rescue/acute and allergy medications among asthmatic patients on controller therapy Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004 Treating smoking asthmatics Source: International Congress 2015 – Asthma and smoking: dangerous liaisons - an interactive session Year: 2015 Pharmacogenetics of anti-inflammatory treatment in children with asthma Source: Annual Congress 2013 –Towards personalised medicine in respiratory diseases in children Year: 2013 Hair analysis to detect chronic inhaler drug use in asthma or COPD patients Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 The effectiveness of anti-IL5 biologics is comparable in previous-smokers and never-smokers with severe asthma Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Efficacy of antiepileptic drugs diphenine and carbamazepine in pharmacotherapy of children with bronchial asthma: is asthma a neurogenic inflammatory disease? Source: Eur Respir J 2006; 28: Suppl. 50, 204s Year: 2006 Rescue/acute and allergy medication use among children on asthma controller therapy Source: Eur Respir J 2004; 24: Suppl. 48, 378s Year: 2004 Combination therapy of inhaled corticosteroids and long-acting beta2-agonists may be associated with risk reduction of lung cancer in COPD patients who quit smoking Source: Eur Respir J 2006; 28: Suppl. 50, 454s Year: 2006 Tobacco smoke and inhaled medications interactions (TIMED) study: asthma and COPD smokers’ habits about inhalers and cigarettes. Preliminary results Source: Annual Congress 2004 - Update on smoking related damage and cessation Year: 2004 Nonadherence with asthma medication in teenagers Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017 Biologic therapies in paediatric severe asthma Source: ERS webinar 2020: Biologic therapies in paediatric severe asthma Year: 2020 Quintupling inhaled glucocorticoids to prevent childhood asthma exacerbations Source: International Congress 2018 – Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose Year: 2018 What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance Source: ERJ Open Res, 7 (1) 00497-2020; 10.1183/23120541.00497-2020 Year: 2021